New · CUSIP 05338F306 · who reports it, how much, and how much it matters to them
31 of the 720 hedge fund managers we track reported shares of Avalo Therapeutics, Inc. (Nasdaq: AVTX) on Form 13F for 30 June 2026. Between them they reported USD 409m. The largest position belongs to Deep Track Capital, at USD 67m. The manager with the most riding on it is Ally Bridge Group (Ny), where it is 2.5% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Deep Track Capital1 fund on PPLI.com | USD 67m | 1.0% |
| 2 | Farallon Capital Management56 funds on PPLI.com | USD 46m | 0.2% |
| 3 | POINT72 Asset Management17 funds on PPLI.com | USD 44m | 0.0% |
| 4 | Avoro Capital Advisors1 fund on PPLI.com | USD 43m | 0.4% |
| 5 | Adage Capital Management1 fund on PPLI.com | USD 32m | 0.0% |
| 6 | Braidwell12 funds on PPLI.com | USD 30m | 1.1% |
| 7 | Logos Global Management1 fund on PPLI.com | USD 21m | 0.9% |
| 8 | Ra Capital Management1 fund on PPLI.com | USD 18m | 0.2% |
| 9 | Balyasny Asset Management25 funds on PPLI.com | USD 16m | 0.0% |
| 10 | Boothbay Fund Management2 funds on PPLI.com | USD 13m | 0.2% |
| 11 | Squarepoint Ops7 funds on PPLI.com | USD 11m | 0.0% |
| 12 | Baker Bros. Advisors2 funds on PPLI.com | USD 10m | 0.1% |
| 13 | Boxer Capital Management1 fund on PPLI.com | USD 6.9m | 0.5% |
| 14 | Renaissance Technologies13 funds on PPLI.com | USD 6.6m | 0.0% |
| 15 | Citadel Advisors32 funds on PPLI.com | USD 6m | 0.0% |
| 16 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 5.7m | 0.0% |
| 17 | Eagle Health Investments1 fund on PPLI.com | USD 4.3m | 0.7% |
| 18 | Sphera Funds Management1 fund on PPLI.com | USD 4.3m | 0.6% |
| 19 | Perceptive Advisors6 funds on PPLI.com | USD 4.1m | 0.1% |
| 20 | Acuta Capital Partners2 funds on PPLI.com | USD 3.4m | 2.4% |
| 21 | Walleye Capital8 funds on PPLI.com | USD 3.4m | 0.0% |
| 22 | RTW Investments2 funds on PPLI.com | USD 3.2m | 0.0% |
| 23 | Ally Bridge Group (Ny)3 funds on PPLI.com | USD 2.8m | 2.5% |
| 24 | HighVista Strategies27 funds on PPLI.com | USD 2.3m | 0.5% |
| 25 | Two Sigma Investments35 funds on PPLI.com | USD 1.2m | 0.0% |
| 26 | Verition Fund Management3 funds on PPLI.com | USD 707,000 | 0.0% |
| 27 | Verdad Advisers6 funds on PPLI.com | USD 607,000 | 0.6% |
| 28 | Persistent Asset Partners10 funds on PPLI.com | USD 454,000 | 0.1% |
| 29 | Exoduspoint Capital Management7 funds on PPLI.com | USD 305,000 | 0.0% |
| 30 | Jain Global1 fund on PPLI.com | USD 234,000 | 0.0% |
| 31 | Eversept Partners3 funds on PPLI.com | USD 185,000 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Ally Bridge Group (Ny) | USD 2.8m | 2.5% |
| 2 | Acuta Capital Partners | USD 3.4m | 2.4% |
| 3 | Braidwell | USD 30m | 1.1% |
| 4 | Deep Track Capital | USD 67m | 1.0% |
| 5 | Logos Global Management | USD 21m | 0.9% |
| 6 | Eagle Health Investments | USD 4.3m | 0.7% |
| 7 | Verdad Advisers | USD 607,000 | 0.6% |
| 8 | Sphera Funds Management | USD 4.3m | 0.6% |
| 9 | Boxer Capital Management | USD 6.9m | 0.5% |
| 10 | HighVista Strategies | USD 2.3m | 0.5% |
Avalo Therapeutics, Inc. trades under the symbol AVTX on the Nasdaq. Its CUSIP, the code used on Form 13F, is 05338F306.
31 of the 720 hedge fund managers PPLI.com tracks reported Avalo Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Deep Track Capital (USD 67m), Farallon Capital Management (USD 46m), POINT72 Asset Management (USD 44m), Avoro Capital Advisors (USD 43m) and Adage Capital Management (USD 32m).
31 managers in our coverage reported it, and between them they run 317 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Ally Bridge Group (Ny), where the position was 2.5% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Avalo Therapeutics, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.